NEW
YORK, Oct. 10, 2023 /PRNewswire/ -- Delcath
Systems, Inc. (Nasdaq: DCTH), an interventional oncology
company focused on the treatment of primary and metastatic cancers
of the liver, announced that it will be participating in the
Lytham Partners Fall 2023 Investor Conference taking place
virtually on Tuesday, October 17,
2023.
Company Webcast
Gerard Michel, CEO, will be
participating in a fireside chat. The Company's webcast
presentation will be available for viewing at 7:00am ET on
Tuesday, October 17, 2023, on the
Company's website at https://delcath.com/investors/
or https://wsw.com/webcast/lytham9/dcth/2022008. The webcast
will also be archived and available for replay.
1x1 Meetings
Management will be participating in virtual one-on-one meetings
throughout the event. To arrange a meeting with management, please
contact Lytham Partners at 1x1@lythampartners.com or register
at https://lythampartners.com/fall2023invreg/.
About Delcath Systems, Inc.
Delcath Systems, Inc. is an interventional oncology company
focused on the treatment of primary and metastatic liver cancers.
The Company's proprietary products, HEPZATO KIT (melphalan for
Injection/Hepatic Delivery System), approved for use in
the United States by FDA, and
CHEMOSAT Hepatic Delivery System for Melphalan percutaneous hepatic
perfusion (PHP), designated under the medical device regulation for
use in Europe and the United Kingdom, are designed to administer
high-dose chemotherapy to the liver while controlling systemic
exposure and associated side effects during a PHP procedure. For
more information regarding HEPZATO KIT and its use, including
Important Safety Information and Boxed Warning, please visit
HEPZATOKIT.com. For more information regarding CHEMOSAT and its
use, please visit Chemosat.com.
Contact:
Investor Relations Contact:
Ben Shamsian
Lytham Partners
646-829-9701
shamsian@lythampartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/delcath-systems-to-participate-in-the-lytham-partners-fall-2023-investor-conference-301951598.html
SOURCE Delcath Systems, Inc.